share_log

Barclays Downgrades Bright Health Gr to Underweight, Raises Price Target to $8

Barclays Downgrades Bright Health Gr to Underweight, Raises Price Target to $8

巴克莱将Bright Health Gr的评级下调至减持,将目标股价上调至8美元
Benzinga ·  2023/06/15 05:52

Barclays analyst Steve Valiquette downgrades Bright Health Gr (NYSE:BHG) from Overweight to Underweight and raises the price target from $4 to $8.

巴克莱分析师史蒂夫·瓦利奎特将Bright Health Gr(纽约证券交易所代码:BHG)的评级从增持下调至减持,并将目标股价从4美元上调至8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发